{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-010458","form_type":"8-K","ticker":"BCAB","cik":"0001826892","company_name":"BioAtla, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.390360+00:00","generated_at":"2026-05-16T10:56:36.268220+00:00","sec_items":["3.02","5.03","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"BioAtla issues super-voting share to CEO; reverse stock split vote fails, adjourned to Jan 26","bullets":["Issued one share of Series A Junior Preferred Stock to CEO Jay Short for $0.01, granting vote power equal to outstanding common shares on reverse split proposals.","At Jan 12, 2026 special meeting, reverse stock split proposal failed to reach required two-thirds vote; meeting adjourned to Jan 26 for additional proxy solicitation.","Over 70% of proxies received were FOR the reverse split, but insufficient to meet two-thirds of outstanding voting power.","Super-Voting Share will automatically vote FOR the reverse split if two-thirds of common shares present vote FOR; else votes AGAINST.","Board set new record date of Jan 12, 2026 for the reconvened meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-010458","json":"https://secwatch.observer/filing/0001193125-26-010458.json","markdown":"https://secwatch.observer/filing/0001193125-26-010458.md","text":"https://secwatch.observer/filing/0001193125-26-010458.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826892/000119312526010458/0001193125-26-010458-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826892/000119312526010458/bcab-20260109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:56:36.268220+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"61761be4c430dc01f28b68d35a57826f45858c08","claim":"BioAtla, Inc.: Filed Certificate of Designation for Series A Junior Preferred Stock (Super-Voting Share) establishing its voting, dividend, liquidation, redemption, and transfer terms (effective 2026-01-09).","evidence_excerpt":"On January 9, 2026, the Company filed a Certificate of Designation of Series A Junior Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware with respect to the Super-Voting Share.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000119312526010458/0001193125-26-010458-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001185185-26-002273","ticker":"DGAC","company_name":"DISCIPLINED GROWTH ACQUISITION Corp","filed_at":"2026-06-01T20:15:34+00:00","headline":"Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: governance_change","same SEC item: 3.02, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-26-002273","json":"https://secwatch.observer/filing/0001185185-26-002273.json","markdown":"https://secwatch.observer/filing/0001185185-26-002273.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/0001185185-26-002273-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/dgac8k052926.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 9, 2026, the Company filed a Certificate of Designation of Series A Junior Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware with respect to the Super-Voting Share.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000119312526010458/0001193125-26-010458-index.htm","comparable_excerpt":"On May 26, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on May 26, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/0001185185-26-002273-index.htm"}},{"accession":"0001829126-26-004879","ticker":"SAGU","company_name":"Shreya Acquisition Group","filed_at":"2026-05-11T23:59:59+00:00","headline":"Shreya Acquisition Group closes $110M IPO, 11M units at $10 each on NYSE","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: governance_change","same SEC item: 3.02, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-004879","json":"https://secwatch.observer/filing/0001829126-26-004879.json","markdown":"https://secwatch.observer/filing/0001829126-26-004879.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2083452/000182912626004879/0001829126-26-004879-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2083452/000182912626004879/shreyaacq_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 9, 2026, the Company filed a Certificate of Designation of Series A Junior Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware with respect to the Super-Voting Share.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000119312526010458/0001193125-26-010458-index.htm","comparable_excerpt":"On May 6, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2083452/000182912626004879/0001829126-26-004879-index.htm"}},{"accession":"0001213900-26-052459","ticker":"QLEP","company_name":"Quantum Leap Acquisition Corp","filed_at":"2026-05-06T23:59:59+00:00","headline":"Quantum Leap Acquisition Corp closes $200M SPAC IPO on NYSE","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: governance_change","same SEC item: 3.02, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-052459","json":"https://secwatch.observer/filing/0001213900-26-052459.json","markdown":"https://secwatch.observer/filing/0001213900-26-052459.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2102155/000121390026052459/0001213900-26-052459-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2102155/000121390026052459/ea0289253-8k_quantum.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 9, 2026, the Company filed a Certificate of Designation of Series A Junior Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware with respect to the Super-Voting Share.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000119312526010458/0001193125-26-010458-index.htm","comparable_excerpt":"In connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies. The Amended and Restated Memorandum and Articles of Association have an effective date of April 29, 2026, being the date on which the special resolution to adopt the Amended and Restated Memorandum and Articles of Association was passed.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2102155/000121390026052459/0001213900-26-052459-index.htm"}},{"accession":"0001829126-26-004565","ticker":"MCAH","company_name":"Mountain Crest Acquisition 6 Corp.","filed_at":"2026-05-05T23:59:59+00:00","headline":"Mountain Crest Acquisition 6 Corp. closes $60M IPO; units start trading April 30","event_type":"other_material","sec_items":["1.01","3.02","5.03","8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: governance_change","same SEC item: 3.02, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-004565","json":"https://secwatch.observer/filing/0001829126-26-004565.json","markdown":"https://secwatch.observer/filing/0001829126-26-004565.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2109876/000182912626004565/0001829126-26-004565-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2109876/000182912626004565/mountaincrest6_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 9, 2026, the Company filed a Certificate of Designation of Series A Junior Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware with respect to the Super-Voting Share.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000119312526010458/0001193125-26-010458-index.htm","comparable_excerpt":"On April 29, 2026, in connection with the IPO, the Company filed its Amended and Restated Memorandum and Articles of Association, as described in the Registration Statement, with the Registry of Corporate Affairs of British Virgin Islands.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2109876/000182912626004565/0001829126-26-004565-index.htm"}},{"accession":"0001213900-26-051060","ticker":"CAII","company_name":"Collective Acquisition Corp. II","filed_at":"2026-05-04T23:59:59+00:00","headline":"Collective Acquisition Corp. II closes $220M IPO; units trade on Nasdaq","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: governance_change","same SEC item: 3.02, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-051060","json":"https://secwatch.observer/filing/0001213900-26-051060.json","markdown":"https://secwatch.observer/filing/0001213900-26-051060.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2115404/000121390026051060/0001213900-26-051060-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2115404/000121390026051060/ea0288564-8k_collective2.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 9, 2026, the Company filed a Certificate of Designation of Series A Junior Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware with respect to the Super-Voting Share.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000119312526010458/0001193125-26-010458-index.htm","comparable_excerpt":"On April 28, 2026, in connection with the Offering, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which became effective on April 28, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2115404/000121390026051060/0001213900-26-051060-index.htm"}},{"accession":"0001193125-26-201578","ticker":"RREV","company_name":"RRE Ventures Acquisition Corp.","filed_at":"2026-05-01T23:59:59+00:00","headline":"RRE Ventures Acquisition Corp. prices and closes $250M IPO; units begin trading on Nasdaq","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: governance_change","same SEC item: 3.02, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-201578","json":"https://secwatch.observer/filing/0001193125-26-201578.json","markdown":"https://secwatch.observer/filing/0001193125-26-201578.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/d77496d8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 9, 2026, the Company filed a Certificate of Designation of Series A Junior Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware with respect to the Super-Voting Share.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000119312526010458/0001193125-26-010458-index.htm","comparable_excerpt":"On April 28, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on April 29, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm"}},{"accession":"0001213900-26-051018","ticker":"DMAA","company_name":"Drugs Made In America Acquisition Corp.","filed_at":"2026-05-01T23:59:59+00:00","headline":"SPAC DMAA shareholders approve extension to April 2027; ~28% of shares redeemed for $99.3M","event_type":"other_material","sec_items":["5.03","5.07","8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 5.07, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-051018","json":"https://secwatch.observer/filing/0001213900-26-051018.json","markdown":"https://secwatch.observer/filing/0001213900-26-051018.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2028614/000121390026051018/0001213900-26-051018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2028614/000121390026051018/ea0288774-8k_drugs.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 9, 2026, the Company filed a Certificate of Designation of Series A Junior Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware with respect to the Super-Voting Share.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000119312526010458/0001193125-26-010458-index.htm","comparable_excerpt":"to amend the Company’s Second Amended and Restated Memorandum and Articles of Association (the “ Existing Charter ”) by adopting an amendment to the Existing Charter in the form set forth in Annex A to the Proxy Statement (the “ Extension Amendment ”) which reflects the extension of the date by which the Company must consummate a business combination (the “ Combination Period ”) up to twelve (12) times from April 29, 2026 (the “ Termination Date ”) to April 29, 2027, each by an additional one (1) month","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390026051018/0001213900-26-051018-index.htm"}},{"accession":"0001062822-26-000065","ticker":"LXRX","company_name":"LEXICON PHARMACEUTICALS, INC.","filed_at":"2026-04-30T23:59:59+00:00","headline":"Lexicon doubles authorized shares to 900M, adopts expanded 2026 equity plans","event_type":"other_material","sec_items":["3.02","5.02","5.03","5.07","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: governance_change","same SEC item: 3.02, 5.03, 5.07, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001062822-26-000065","json":"https://secwatch.observer/filing/0001062822-26-000065.json","markdown":"https://secwatch.observer/filing/0001062822-26-000065.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000065/0001062822-26-000065-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000065/lxrx-20260430.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 9, 2026, the Company filed a Certificate of Designation of Series A Junior Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware with respect to the Super-Voting Share.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000119312526010458/0001193125-26-010458-index.htm","comparable_excerpt":"The Seventh Amended and Restated Certificate of Incorporation increases the number of shares of our authorized Common Stock from 450,000,000 to 900,000,000.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000065/0001062822-26-000065-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}